NASDAQ: CLVS       Clovis Oncology Inc
Last Price Today's Change   Day's Range   Trading Volume
9.85   +0.375 (3.96%)  9.36 - 10.19  14,199,600


Avg Volume (4 weeks):8,281,733
4 Weeks Range:8.11 - 12.04
4 Weeks Price Volatility (%):
52 Weeks Range:2.93 - 32.05
52 Weeks Price Volatility (%):
Average Price Target: 26.50
Price Target Upside/Downside: +16.65


No recent Headlines for this stock.

Business Background

Clovis Oncology Inc is operative in the healthcare sector based in the United States. As a pharmaceutical manufacturer, it is focused on developing and commercializing anti-cancer agents. Its suite of product candidates includes Rociletinib, Rucaparib and Lucitanib. Rociletinib is an oral epidermal growth factor receptor (EGFR), mutant-selective covalent inhibitor for the treatment of non-small cell lung cancer. Rucaparib is an oral inhibitor of poly (ADP-ribose) polymerase (PARP) that is in advanced clinical development for the treatment of ovarian cancer. The company's revenue primarily depends on the sale of Rucaparib in the United States market.

  Be the first to like this.


3414  4674  636  186 

Top 10 Active Counters
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers